LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 388 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $245,249 | +9.8% | 3,334 | -0.3% | 0.00% | – |
| Q4 2022 | $223,379 | -23.0% | 3,344 | -0.7% | 0.00% | – |
| Q3 2022 | $290,000 | -4.0% | 3,367 | -0.6% | 0.00% | – |
| Q2 2022 | $302,000 | -23.2% | 3,388 | -3.1% | 0.00% | – |
| Q1 2022 | $393,000 | -27.2% | 3,498 | 0.0% | 0.00% | – |
| Q4 2021 | $540,000 | +10.9% | 3,498 | 0.0% | 0.00% | – |
| Q3 2021 | $487,000 | +1.2% | 3,498 | -4.5% | 0.00% | – |
| Q2 2021 | $481,000 | -81.7% | 3,664 | -78.7% | 0.00% | -100.0% |
| Q1 2021 | $2,628,000 | +0.9% | 17,237 | -34.2% | 0.00% | 0.0% |
| Q4 2020 | $2,604,000 | +2.2% | 26,186 | -2.1% | 0.00% | 0.0% |
| Q3 2020 | $2,549,000 | +26.8% | 26,744 | +48.8% | 0.00% | 0.0% |
| Q2 2020 | $2,010,000 | +196.5% | 17,971 | +92.7% | 0.00% | +200.0% |
| Q1 2020 | $678,000 | -37.0% | 9,328 | -9.7% | 0.00% | 0.0% |
| Q4 2019 | $1,077,000 | -7.7% | 10,327 | -11.9% | 0.00% | -50.0% |
| Q3 2019 | $1,167,000 | -17.4% | 11,721 | -5.3% | 0.00% | 0.0% |
| Q2 2019 | $1,412,000 | -4.9% | 12,374 | +4.7% | 0.00% | 0.0% |
| Q1 2019 | $1,485,000 | -20.8% | 11,815 | -14.5% | 0.00% | -33.3% |
| Q4 2018 | $1,876,000 | -60.3% | 13,821 | -19.8% | 0.00% | -57.1% |
| Q3 2018 | $4,730,000 | +40.6% | 17,232 | +6.1% | 0.01% | +16.7% |
| Q2 2018 | $3,365,000 | +27.9% | 16,245 | +2.0% | 0.01% | +20.0% |
| Q1 2018 | $2,631,000 | +102.9% | 15,928 | +68.2% | 0.01% | +150.0% |
| Q4 2017 | $1,297,000 | +8.8% | 9,471 | +8.2% | 0.00% | 0.0% |
| Q3 2017 | $1,192,000 | +13.3% | 8,752 | +1.0% | 0.00% | 0.0% |
| Q2 2017 | $1,052,000 | +17.8% | 8,664 | +2.6% | 0.00% | 0.0% |
| Q1 2017 | $893,000 | +9.0% | 8,441 | +4.8% | 0.00% | 0.0% |
| Q4 2016 | $819,000 | +27.4% | 8,056 | +27.9% | 0.00% | 0.0% |
| Q3 2016 | $643,000 | -50.3% | 6,298 | -42.0% | 0.00% | -50.0% |
| Q2 2016 | $1,295,000 | +129.6% | 10,856 | +106.1% | 0.00% | +100.0% |
| Q1 2016 | $564,000 | – | 5,268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |